3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Multiple Myeloma
277
Precursor Cell Lymphoblastic Leukemia-Lymphoma
55
Recurrence
43
Neoplasms, Plasma Cell
32
Leukemia
29
Lymphoma
25
Neoplasms
23
Vomiting
21
Burkitt Lymphoma
20
Lymphoma, Non-Hodgkin
19
Nausea
17
Immunoglobulin Light-chain Amyloidosis
17
Lymphoma, Mantle-Cell
16
Carcinoma, Non-Small-Cell Lung
15
Prostatic Neoplasms
14
Waldenstrom Macroglobulinemia
13
Lymphoma, Follicular
13
Breast Neoplasms
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, Large B-Cell, Diffuse
11
Leukemia, Myeloid, Acute
10
Lymphoma, B-Cell, Marginal Zone
9
Amyloidosis
9
Leukemia, Lymphocytic, Chronic, B-Cell
8
Hodgkin Disease
8
Neoplasm Metastasis
7
Hematologic Neoplasms
7
Smoldering Multiple Myeloma
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Interventions
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Systemic Inflammatory Response Syndrome
×
Dexamethasone
×
Clear all
NCT03125941
2019-12-02
DEX-MAS
Rigshospitalet, Denmark
Phase 4
Completed
130 enrolled
20 charts